Back
8x8 Vs. Lyra Therapeutics Industry Stock Comparison
Buy
55
EGHT
8x8
Last Price:
$2.06
Seasonality Move:
8.35%
Sell
20
LYRA
Lyra Therapeutics
Last Price:
$9.04
Seasonality Move:
-2.29%
Sell
20
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $9.06. The Score for LYRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EGHT Stock Price Chart
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $9.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing slight buying pressure.
EGHT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 58.85 | Buy |
Chaikin Money Flow: | -618690 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.76 - 2.04) | Buy |
Bollinger Bands (100): | (1.62 - 2.38) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.73 | Buy |
Relative Strength Index (14 RSI): | 44.53 | Sell |
Chaikin Money Flow: | 4052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.91 - 17.51) | Sell |
Bollinger Bands (100): | (4.03 - 13.13) | Buy |
EGHT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.09 | Sell |
20-day SMA: | 1.92 | Buy |
50-day SMA: | 1.82 | Buy |
200-day SMA: | 2.28 | Sell |
8-day EMA: | 1.12 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.24 | Buy |
200-day EMA: | 0.06 | Buy |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.1 | Sell |
20-day SMA: | 10.57 | Sell |
50-day SMA: | 9.65 | Sell |
200-day SMA: | 9.68 | Sell |
8-day EMA: | 4.86 | Buy |
20-day EMA: | 2.39 | Buy |
50-day EMA: | 1.04 | Buy |
200-day EMA: | 0.27 | Buy |
8x8 Earnings Growth & EGHT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.01 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
8x8 Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |